Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

OTC Healthcare in France to 2011

Published by: Datamonitor

Published: Jul. 31, 2008 - 184 Pages


Table of Contents


Chapter 1 EXECUTIVE SUMMARY
Summary Market Level - OTC Healthcare
Summary category level - Analgesics
Summary category level - Cough and Cold Preparations
Summary category level - Traditional Medicines
Summary category level - First Aid Kits
Summary category level - Indigestion Preparations
Summary category level - Vitamins and Minerals
Summary category level - Plasters & Bandages
Summary category level - Medicated Skin Products
Summary category level - Other OTC Healthcare Products
Summary category level - Topical OTC Medicines
Chapter 2 INTRODUCTION
What is this report about?
How to use this report
Market Definition
Chapter 3 MARKET OVERVIEW
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 4 LEADING COMPANY PROFILES
Procter & Gamble Company, The
Sanofi-Aventis Group
Chapter 5 CATEGORY ANALYSIS - ANALGESICS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 15 COUNTRY COMPARISON
Value
Market Share
Chapter 16 NEW PRODUCT DEVELOPMENT
Product launches over time
Recent product launches
Chapter 17 FRANCE SOCIOECONOMIC PROFILE
Country Overview
Key Facts
Political Overview
France Economic Overview
Chapter 18 FRANCE MACROECONOMIC PROFILE
Macroeconomic Indicators
Chapter 19 RESEARCH METHODOLOGY
Methodology overview
Secondary research
Market modelling
Primary research
Data finalisation
Ongoing research
Chapter 20 APPENDIX
Future readings
How to contact experts in your industry
LIST OF FIGURES
Figure 1: France OTC Healthcare value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 2: France OTC Healthcare category growth comparison, by value, 2001-2011
Figure 3: France OTC Healthcare company share, by value, 2005-2006 (%)
Figure 4: France Analgesics value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 5: France Analgesics category growth comparison, by value, 2001-2011
Figure 6: France Analgesics company share, by value, 2005-2006 (%)
Figure 7: France Cough and Cold Preparations value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 8: France Cough and Cold Preparations category growth comparison, by value, 2001-2011
Figure 9: France Cough and Cold Preparations company share, by value, 2005-2006 (%)
Figure 10: France Traditional Medicines value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 11: France First Aid Kits value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 12: France First Aid Kits company share, by value, 2005-2006 (%)
Figure 13: France Indigestion Preparations value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 14: France Indigestion Preparations category growth comparison, by value, 2001-2011
Figure 15: France Indigestion Preparations company share, by value, 2005-2006 (%)
Figure 16: France Vitamins and Minerals value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 17: France Vitamins and Minerals category growth comparison, by value, 2001-2011
Figure 18: France Plasters & Bandages value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 19: France Plasters & Bandages category growth comparison, by value, 2001-2011
Figure 20: France Plasters & Bandages company share, by value, 2005-2006 (%)
Figure 21: France Medicated Skin Products value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 22: France Medicated Skin Products category growth comparison, by value, 2001-2011
Figure 23: France Medicated Skin Products company share, by value, 2005-2006 (%)
Figure 24: France Other OTC Healthcare Products value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 25: France Other OTC Healthcare Products category growth comparison, by value, 2001-2011
Figure 26: France Other OTC Healthcare Products company share, by value, 2005-2006 (%)
Figure 27: France Topical OTC Medicines value & value forecast, 2001-2011 (EUR m, nominal prices)
Figure 28: France Topical OTC Medicines category growth comparison, by value, 2001-2011
Figure 29: France Topical OTC Medicines company share, by value, 2005-2006 (%)
Figure 30: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries
Figure 31: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries)
Figure 32: Map of France
Figure 33: Annual data review process
LIST OF TABLES
Table 1: OTC Healthcare category definitions
Table 2: France OTC Healthcare value, 2001-2006 (EUR m, nominal prices)
Table 3: France OTC Healthcare value forecast, 2006-2011 (EUR m, nominal prices)
Table 4: France OTC Healthcare value, 2001-2006 (US$ m nominal prices)
Table 5: France OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices)
Table 6: France OTC Healthcare brand share, by value, 2005-2006 (%)
Table 7: France OTC Healthcare value, by brand 2005-2006 (EUR m nominal prices)
Table 8: France OTC Healthcare company share by value, 2005-2006 (%)
Table 9: France OTC Healthcare value, by company, 2005-2006 (EUR m nominal prices)
Table 10: France OTC Healthcare expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 11: France OTC Healthcare forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 12: France OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices)
Table 13: France OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 14: Procter & Gamble Company, The Key Facts
Table 15: Sanofi-Aventis Group Key Facts
Table 16: France Analgesics value, 2001-2006 (EUR m, nominal prices)
Table 17: France Analgesics value forecast, 2006-2011 (EUR m, nominal prices)
Table 18: France Analgesics value, 2001-2006 (US$ m nominal prices)
Table 19: France Analgesics value forecast, 2006-2011 (US$ m nominal prices)
Table 20: France Analgesics brand share, by value, 2005-2006 (%)
Table 21: France Analgesics value, by brand 2005-2006 (EUR m nominal prices)
Table 22: France Analgesics company share by value, 2005-2006 (%)
Table 23: France Analgesics value, by company, 2005-2006 (EUR m nominal prices)
Table 24: France Analgesics expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 25: France Analgesics forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 26: France Analgesics expenditure per capita, 2001-2006 (US$ nominal prices)
Table 27: France Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 28: France Cough and Cold Preparations value, 2001-2006 (EUR m, nominal prices)
Table 29: France Cough and Cold Preparations value forecast, 2006-2011 (EUR m, nominal prices)
Table 30: France Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices)
Table 31: France Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices)
Table 32: France Cough and Cold Preparations brand share, by value, 2005-2006 (%)
Table 33: France Cough and Cold Preparations value, by brand 2005-2006 (EUR m nominal prices)
Table 34: France Cough and Cold Preparations company share by value, 2005-2006 (%)
Table 35: France Cough and Cold Preparations value, by company, 2005-2006 (EUR m nominal prices)
Table 36: France Cough and Cold Preparations expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 37: France Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 38: France Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
Table 39: France Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 40: France Traditional Medicines value, 2001-2006 (EUR m, nominal prices)
Table 41: France Traditional Medicines value forecast, 2006-2011 (EUR m, nominal prices)
Table 42: France Traditional Medicines value, 2001-2006 (US$ m nominal prices)
Table 43: France Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices)
Table 44: France Traditional Medicines brand share, by value, 2005-2006 (%)
Table 45: France Traditional Medicines value, by brand 2005-2006 (EUR m nominal prices)
Table 46: France Traditional Medicines company share by value, 2005-2006 (%)
Table 47: France Traditional Medicines value, by company, 2005-2006 (EUR m nominal prices)
Table 48: France Traditional Medicines expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 49: France Traditional Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 50: France Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
Table 51: France Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 52: France First Aid Kits value, 2001-2006 (EUR m, nominal prices)
Table 53: France First Aid Kits value forecast, 2006-2011 (EUR m, nominal prices)
Table 54: France First Aid Kits value, 2001-2006 (US$ m nominal prices)
Table 55: France First Aid Kits value forecast, 2006-2011 (US$ m nominal prices)
Table 56: France First Aid Kits brand share, by value, 2005-2006 (%)
Table 57: France First Aid Kits value, by brand 2005-2006 (EUR m nominal prices)
Table 58: France First Aid Kits company share by value, 2005-2006 (%)
Table 59: France First Aid Kits value, by company, 2005-2006 (EUR m nominal prices)
Table 60: France First Aid Kits expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 61: France First Aid Kits forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 62: France First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices)
Table 63: France First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 64: France Indigestion Preparations value, 2001-2006 (EUR m, nominal prices)
Table 65: France Indigestion Preparations value forecast, 2006-2011 (EUR m, nominal prices)
Table 66: France Indigestion Preparations value, 2001-2006 (US$ m nominal prices)
Table 67: France Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices)
Table 68: France Indigestion Preparations brand share, by value, 2005-2006 (%)
Table 69: France Indigestion Preparations value, by brand 2005-2006 (EUR m nominal prices)
Table 70: France Indigestion Preparations company share by value, 2005-2006 (%)
Table 71: France Indigestion Preparations value, by company, 2005-2006 (EUR m nominal prices)
Table 72: France Indigestion Preparations expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 73: France Indigestion Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 74: France Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
Table 75: France Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 76: France Vitamins and Minerals value, 2001-2006 (EUR m, nominal prices)
Table 77: France Vitamins and Minerals value forecast, 2006-2011 (EUR m, nominal prices)
Table 78: France Vitamins and Minerals value, 2001-2006 (US$ m nominal prices)
Table 79: France Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices)
Table 80: France Vitamins and Minerals brand share, by value, 2005-2006 (%)
Table 81: France Vitamins and Minerals value, by brand 2005-2006 (EUR m nominal prices)
Table 82: France Vitamins and Minerals company share by value, 2005-2006 (%)
Table 83: France Vitamins and Minerals value, by company, 2005-2006 (EUR m nominal prices)
Table 84: France Vitamins and Minerals expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 85: France Vitamins and Minerals forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 86: France Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices)
Table 87: France Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 88: France Plasters & Bandages value, 2001-2006 (EUR m, nominal prices)
Table 89: France Plasters & Bandages value forecast, 2006-2011 (EUR m, nominal prices)
Table 90: France Plasters & Bandages value, 2001-2006 (US$ m nominal prices)
Table 91: France Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices)
Table 92: France Plasters & Bandages brand share, by value, 2005-2006 (%)
Table 93: France Plasters & Bandages value, by brand 2005-2006 (EUR m nominal prices)
Table 94: France Plasters & Bandages company share by value, 2005-2006 (%)
Table 95: France Plasters & Bandages value, by company, 2005-2006 (EUR m nominal prices)
Table 96: France Plasters & Bandages expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 97: France Plasters & Bandages forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 98: France Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices)
Table 99: France Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 100: France Medicated Skin Products value, 2001-2006 (EUR m, nominal prices)
Table 101: France Medicated Skin Products value forecast, 2006-2011 (EUR m, nominal prices)
Table 102: France Medicated Skin Products value, 2001-2006 (US$ m nominal prices)
Table 103: France Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices)
Table 104: France Medicated Skin Products brand share, by value, 2005-2006 (%)
Table 105: France Medicated Skin Products value, by brand 2005-2006 (EUR m nominal prices)
Table 106: France Medicated Skin Products company share by value, 2005-2006 (%)
Table 107: France Medicated Skin Products value, by company, 2005-2006 (EUR m nominal prices)
Table 108: France Medicated Skin Products expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 109: France Medicated Skin Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 110: France Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices)
Table 111: France Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 112: France Other OTC Healthcare Products value, 2001-2006 (EUR m, nominal prices)
Table 113: France Other OTC Healthcare Products value forecast, 2006-2011 (EUR m, nominal prices)
Table 114: France Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices)
Table 115: France Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices)
Table 116: France Other OTC Healthcare Products brand share, by value, 2005-2006 (%)
Table 117: France Other OTC Healthcare Products value, by brand 2005-2006 (EUR m nominal prices)
Table 118: France Other OTC Healthcare Products company share by value, 2005-2006 (%)
Table 119: France Other OTC Healthcare Products value, by company, 2005-2006 (EUR m nominal prices)
Table 120: France Other OTC Healthcare Products expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 121: France Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 122: France Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices)
Table 123: France Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 124: France Topical OTC Medicines value, 2001-2006 (EUR m, nominal prices)
Table 125: France Topical OTC Medicines value forecast, 2006-2011 (EUR m, nominal prices)
Table 126: France Topical OTC Medicines value, 2001-2006 (US$ m nominal prices)
Table 127: France Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices)
Table 128: France Topical OTC Medicines brand share, by value, 2005-2006 (%)
Table 129: France Topical OTC Medicines value, by brand 2005-2006 (EUR m nominal prices)
Table 130: France Topical OTC Medicines company share by value, 2005-2006 (%)
Table 131: France Topical OTC Medicines value, by company, 2005-2006 (EUR m nominal prices)
Table 132: France Topical OTC Medicines expenditure per capita, 2001-2006 (EUR, nominal prices)
Table 133: France Topical OTC Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices)
Table 134: France Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
Table 135: France Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 136: Global OTC Healthcare market value, 2006
Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries
Table 138: Leading players - Top 5 countries
Table 139: France OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006
Table 140: France OTC Healthcare new product launches (reports), by flavor and fragrances (Top 10 flavors), 2006
Table 141: France OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006
Table 142: France OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006
Table 143: France OTC Healthcare new product launches (reports) - Recent 5 launches
Table 144: France Key Facts
Table 145: France population, by age group, 2000-2005 (millions)
Table 146: France population forecast, by age group, 2005-2010 (millions)
Table 147: France population, by gender, 2000-2005 (millions)
Table 148: France population forecast, by gender, 2005-2010 (millions)
Table 149: France real GDP, 2000-2005 (EUR bn, 2005 prices)
Table 150: France real GDP forecast, 2005-2010 (EUR bn, 2005 prices)
Table 151: France nominal GDP, 2000-2005 (EUR bn, nominal prices)
Table 152: France real GDP, 2000-2005 (US$ bn, 2005 prices)
Table 153: France real GDP forecast, 2005-2010 (US$ bn, 2005 prices)
Table 154: France consumer price index, 2000-2005 (2000=100)
Table 155: France consumer price index, 2005-2010 (2000=100)
Table 156: France exchange rate, 2000-2005

Abstract

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in France. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope
  • Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
  • Provides market value, volume, expenditure and consumption data by market, segment and subsegment
  • Includes company and brand share data by categories
Highlights

The market for OTC Healthcare in France increased between 2001-2006, growing at an average annual rate of 2.2%.

The leading company in the market in 2006 was Procter & Gamble Company, The. The second-largest player was Sanofi-Aventis Group with Pfizer Inc in third place.

Reasons to Purchase
  • Discover the major quantitative trends affecting the OTC Healthcare markets
  • Understand consumers' consumption and expenditure patterns
  • Understand the future direction of the market with reliable historical data and full five year forecasting


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008